I hear you, but I think if our trial design was be

I hear you, but I think if our trial design was better and the results were what they should have been, it would have been irrefutable. The FDA cannot deny results that adhere to their terms and that are made public. As we have said many times, CYDY gave the FDA plenty of ammunition to deny leronlimab for severe/critical. And it cost tens of thousands of lives, as it is currently doing overseas as well. Horrible.

Agreed, let's see how Brazil goes. I am 100% open to that and if NP and crew can finally get the ball across the goal line, well then good for everyone. Philippines and India? Neither seems to care much about the potential for saving lives in their countries at the moment, at least not with leronlimab. Again, horrible. Sad.